Baker McKenzie advised a syndicate consisting of 12 international banks on a USD 7.5 billion multicurrency revolving credit facility agreement for Roche Holding AG. Deutsche Bank acted as coordinator, arranger, facility agent and swingline agent.
Roche (SWX: ROG) is a global leader in pharmaceuticals and diagnostics, with a presence in more than 100 countries worldwide. The company delivers a comprehensive portfolio of innovative medicines and diagnostic solutions across major disease areas, including oncology, immunology, neuroscience, infectious diseases and ophthalmology.
Baker McKenzie advised the lenders on all legal and tax aspects of the transaction. The team was led by Charlotte Rüegg and Markus Wolf (both Banking and Finance, Zurich), and included Andrea Bolliger (Tax, Zurich), Lyubomir Georgiev (US Tax, Zurich), Miju Damodar (Banking and Finance, New York) and Anna Berneis (Trainee Lawyer, Zurich).